Lipid profile of type 2 diabetic and hypertensive patients in the jamaican population

Lorenzo Gordon1, Dalip Ragoobirsingh, Errol Y A Morrison

  • 1Department of Medicine, The University of the West Indies, Kingston 7, Jamaica.

Insights

Type 2 diabetes and hypertension increase lipid levels, particularly in females. Hypertensive type 2 diabetic females show higher total cholesterol, indicating a greater risk of cardiovascular disease.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • Diabetes mellitus (DM) is a known risk factor for cardiovascular diseases (CVDs), with a disproportionately higher risk observed in females compared to males.
  • Understanding lipid profile variations in diabetic populations is crucial for assessing CVD risk.

Purpose of the Study:

  • To evaluate and compare the lipid profiles of males and females with type 2 diabetes.
  • To investigate potential sex-based differences in lipid dysregulation within diabetic and hypertensive diabetic cohorts.

Main Methods:

  • A cross-sectional study involving type 2 diabetic patients and hypertensive type 2 diabetic patients (aged 15+).
  • Analysis of lipid profiles, including Total Cholesterol (TC), Triglycerides (TG), LDL-C, VLDL-C, and HDL-C, using standard biochemical assays.
  • Comparison of lipid parameters between sexes and between diabetic/hypertensive diabetic groups and controls.

Main Results:

  • Type 2 diabetic and hypertensive type 2 diabetic patients exhibited higher lipid concentrations and ratios compared to non-diabetic controls, though not always statistically significant.
  • Hypertensive type 2 diabetic females showed significantly higher serum Total Cholesterol (TC) than hypertensive non-diabetic males.
  • While most lipid parameters were non-significantly higher in females, TC was notably elevated in hypertensive type 2 diabetic females.

Conclusions:

  • Dyslipidemia is prevalent in the studied type 2 diabetic population.
  • Hypertensive type 2 diabetic females present with higher Total Cholesterol compared to their male counterparts, suggesting increased atherogenic risk.
  • These findings highlight a potentially greater susceptibility of hypertensive type 2 diabetic females to cardiovascular risk factors, including atherogenic dyslipidemia.
Abstract

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...